TC Biopharm (TCBPW) Competitors $0.02 +0.01 (+94.00%) (As of 02:22 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesShort InterestTrends TCBPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. TC Biopharm vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote TC Biopharm (NASDAQ:TCBPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership. Does the MarketBeat Community believe in TCBPW or ATNFW? TC Biopharm and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformTC BiopharmN/AN/A180 Life SciencesN/AN/A Does the media prefer TCBPW or ATNFW? In the previous week, TC Biopharm's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that TC Biopharm is being referred to more favorably in the media. Company Overall Sentiment TC Biopharm Very Positive 180 Life Sciences Very Positive Is TCBPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets TC BiopharmN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has higher earnings and valuation, TCBPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTC Biopharm$2.86MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryTC Biopharm beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Ad WealthPressIs the Trump/Musk duo good for shares of TSLA?If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCBPW vs. The Competition Export to ExcelMetricTC BiopharmBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$202.92M$5.15B$9.28BDividend YieldN/A3.54%4.81%4.06%P/E RatioN/A317.19135.4217.51Price / SalesN/A15,267.141,184.62142.21Price / CashN/A11.6740.4237.95Price / BookN/A7.264.894.94Net IncomeN/A-$18.52M$118.71M$225.59M7 Day PerformanceN/A185.66%15.74%-1.07%1 Month PerformanceN/A133.72%15.70%7.23%1 Year PerformanceN/A113.83%34.85%22.97% TC Biopharm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCBPWTC BiopharmN/A$0.02+94.0%N/A-50.0%$0.00$2.86M0.0080Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.01flatN/A+41.0%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare AcquisitionN/A$0.04flatN/A+4.1%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.05+142.2%N/AN/A$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$2.50-3.8%N/A+12.9%$0.00$391.87M0.004Gap UpALVOAlvotech2.7632 of 5 stars$11.28-1.1%$18.00+59.6%+13.9%$0.00$93.38M-6.101,026ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.04+29.0%N/AN/A$0.00N/A0.004ACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.11+9.8%N/A+263.0%$0.00$35.36M0.0070Positive NewsBTMDWbioteN/A$0.45+2.3%N/AN/A$0.00$193.06M0.00N/A Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCBPW) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredFREE Book That Could Make You a Millionaire[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.